Granules India Limited (BOM: 532482)

Market Cap	168.30B
Revenue (ttm)	47.01B
Net Income (ttm)	4.92B
Shares Out	242.37M
EPS (ttm)	20.28
PE Ratio	34.23
Forward PE	26.36
Dividend	1.50 (0.22%)
Ex-Dividend Date	Jul 30, 2024

Volume	43,063
Open	670.00
Previous Close	666.40
Day's Range	666.85 - 696.95
52-Week Range	306.05 - 724.55
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Granules India

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules Ind...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 4,057
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532482

Financial Performance

In 2023, Granules India's revenue was 45.06 billion, a decrease of -0.12% compared to the previous year's 45.12 billion. Earnings were 4.05 billion, a decrease of -21.54%.